Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/149329
Full metadata record
DC FieldValueLanguage
dc.creatorBarbosa, M-
dc.creatorAlves, PM-
dc.creatorCosta, F-
dc.creatorMonteiro, C-
dc.creatorParreira, P-
dc.creatorTeixeira, C-
dc.creatorGomes, P-
dc.creatorMartins, MCL-
dc.date.accessioned2023-05-17T12:26:22Z-
dc.date.available2023-05-17T12:26:22Z-
dc.date.issued2023-
dc.identifier.issn1999-4923-
dc.identifier.urihttps://hdl.handle.net/10216/149329-
dc.description.abstractIt is key to fight bacterial adhesion to prevent biofilm establishment on biomaterials. Surface immobilization of antimicrobial peptides (AMP) is a promising strategy to avoid bacterial colonization. This work aimed to investigate whether the direct surface immobilization of Dhvar5, an AMP with head-to-tail amphipathicity, would improve the antimicrobial activity of chitosan ultrathin coatings. The peptide was grafted by copper-catalyzed azide-alkyne cycloaddition (CuAAC) chemistry by either its C- or N- terminus to assess the influence of peptide orientation on surface properties and antimicrobial activity. These features were compared with those of coatings fabricated using previously described Dhvar5-chitosan conjugates (immobilized in bulk). The peptide was chemoselectively immobilized onto the coating by both termini. Moreover, the covalent immobilization of Dhvar5 by either terminus enhanced the antimicrobial effect of the chitosan coating by decreasing colonization by both Gram-positive (Staphylococcus aureus, Staphylococcus epidermidis) and Gram-negative (Escherichia coli, Pseudomonas aeruginosa) bacteria. Relevantly, the antimicrobial performance of the surface on Gram-positive bacteria depended on how Dhvar5-chitosan coatings were produced. An antiadhesive effect was observed when the peptide was grafted onto prefabricated chitosan coatings (film), and a bactericidal effect was exhibited when coatings were prepared from Dhvar5-chitosan conjugates (bulk). This antiadhesive effect was not due to changes in surface wettability or protein adsorption but rather depended on variations in peptide concentration, exposure, and surface roughness. Results reported in this study show that the antibacterial potency and effect of immobilized AMP vary greatly with the immobilization procedure. Overall, independently of the fabrication protocol and mechanism of action, Dhvar5-chitosan coatings are a promising strategy for the development of antimicrobial medical devices, either as an antiadhesive or contact-killing surface.pt_PT
dc.description.sponsorshipThis work was financed by the FCT- Fundação para a Ciência e a Tecnologia through projects POCI-01-0145-FEDER-031781 (AntINFECT), UIB/50006/2020 (LAQV-REQUIMTE) and FEDER—Fundo Europeu de Desenvolvimento Regional through NORTE 2020—Programa Operacional Regional do Norte-Bio2Skin Advanced (NORTE-01-0247-FEDER-047225). M Barbosa (SFRH/BD/108966/2015) and Pedro Alves (SFRH/BD/145471/2019) Ph.D. grants were financially supported by national (FCT/Norte 2020 Framework) and European Union funds (ESF—European Social Fund). Paula Parreira (CEECIND/01210/2018) and Maria Cristina L. Martins (LA/P/0070/2020) also thank FCT for funding. Maria Cristina L. Martins also acknowledges the MOBILIsE Project, which has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement no. 951723.-
dc.language.isoengpt_PT
dc.publisherMDPIpt_PT
dc.relationinfo:eu-repo/grantAgreement/FCT/FARH/SFRH%2FBD%2F108966%2F2015/PT|| info:eu-repo/grantAgreement/FCT/POR_NORTE/SFRH%2FBD%2F145471%2F2019/PT-
dc.relation.ispartofseriesPharmaceutics 2023, Vol. 15(5):510pt_PT
dc.rightsopenAccesspt_PT
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectAntimicrobial peptidespt_PT
dc.subjectBacterial adhesionpt_PT
dc.subjectBiomaterialspt_PT
dc.subjectChitosanpt_PT
dc.subjectSurface characterizationpt_PT
dc.subjectSurface modificationpt_PT
dc.titleInfluence of Immobilization Strategies on the Antibacterial Properties of Antimicrobial Peptide-Chitosan Coatingspt_PT
dc.typeArtigo em Revista Científica Internacionalpt_PT
dc.contributor.uportoInstituto de Investigação e Inovação em Saúdept_PT
dc.identifier.doi10.3390/pharmaceutics15051510-
dc.relation.publisherversionhttps://www.mdpi.com/1999-4923/15/5/1510-
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
BarbosaM-2023_pharmaceutics-15-01510.pdf3.91 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons